A new study showed that for people who were susceptible to psychosis, cannabis use in their 30s was associated with an earlier onset of psychosis by 6.3 years.
Articles on Medicinal cannabis
Displaying 1 - 20 of 39 articles
Anxiety, psychosis and paranoia are among adverse events people are reporting after using higher-strength medicinal cannabis, according to a new study.
We asked 5 experts if clinics should be allowed to prescribe medicinal cannabis if they have financial links to the supplier or dispenser. Here’s what they said.
Parents want to see if medicinal cannabis can help their child’s behavioural or emotional problems. But the evidence isn’t in and there are potential safety concerns.
Many Australians are taking medicinal cannabis for their anxiety, depression and post-traumatic stress disorder. But does it actually work?
Nobody wants impaired drivers on the road. But if you take medicinal cannabis and need to drive, here are some options to minimise the risk.
Put on your legal glasses for a moment. Then take our quick quiz to see if you can spot how this medicinal cannabis website bends the rules.
More people are accessing medicinal cannabis than ever expected, or the health system was designed for. And we’re failing patients.
Medicinal cannabis scripts are rising and reports of side effects are likely an underestimate. Here’s what we know about the risks.
Medicinal cannabis use has increased rapidly in Australia over recent years. But there’s limited evidence it helps the conditions it’s most commonly prescribed for.
As more and more people receive medicinal cannabis prescriptions, we’re left with a system that is misaligned with its original purpose.
The latest announcement doesn’t tighten existing prescribing or marketing rules for medicinal cannabis. It just reminds health professionals what the rules are.
Women are less likely than men to get a prescription for medicinal cannabis, and they tend not to disclose their use out of fear of societal rejection.
One in five people experience chronic pain. Here’s how likely you are to find relief with medicinal cannabis.
Aggressive and misleading marketing is fuelling demand for medicinal cannabis. Here are some of the ways clinics bend the rules.
Hemp flowers and certain cannabis products contain fungal toxins, including Aspergillus and Fusarium, that can exceed acceptable regulatory levels.
You’ve tried everything to get some sleep, but nothing’s working. Here’s what not to do, and what works.
Medicinal cannabis products were made legal in New Zealand in 2020. But high costs and widespread reluctance from doctors means many sick people are still accessing cannabis illegally.
Ensuring the participation of ordinary citizens and producers in the industry is the big challenge facing African states.
The TGA gave low-dose cannabis sales without prescription the green light in February. But no product has jumped through all the regulatory hoops to market yet.
Top contributors
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
NHMRC Postgraduate Scholar and Fulbright Alumna in Public Health Policy, Monash University
-
Senior Research Fellow, Department of General Practice and Primary Care, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne
-
Emeritus Consultant, St Vincent's Hospital, Darlinghurst
-
Lecturer in Law, Sydney Law School, University of Sydney
-
Associate Professor in Drug Policy and Health Law, Te Kunenga ki Pūrehuroa – Massey University
-
PhD candidate, College of Health, Te Kunenga ki Pūrehuroa – Massey University
-
Professor of Policy and Health, Te Kunenga ki Pūrehuroa – Massey University
-
NHMRC Emerging Leadership Fellow, National Centre for Youth Substance Use Research, The University of Queensland
-
Professor, Faculty of Law, University of Technology Sydney
-
Principal Communications and Events Officer Centre for Medicinal Cannabis Research and Innovation Office of the NSW Chief Scientist & Engineer, Office of the Chief Scientist
-
PhD candidate, UCL
-
Campus Visitor at the National Centre for Epidemiology and Population Health, Australian National University
-
Senior Research Fellow, Monash University
-
Associate Professor of Leadership, Swinburne University of Technology